Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Magoola

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biomedicines|April 27, 2024
Transcytosis-Driven Treatment of Neurodegenerative Disorders by mRNA-Expressed Antibody-Transferrin ConjugatesSarfaraz K Niazi, Matthias Magoola
International Journal of Molecular Sciences|December 17, 2024
MicroRNA Nobel Prize: Timely Recognition and High Anticipation of Future Products-A Prospective AnalysisSarfaraz K Niazi, Matthias Magoola
Cancers|June 13, 2025
Current Progress and Future Perspectives of RNA-Based Cancer Vaccines: A 2025 UpdateMatthias Magoola, Sarfaraz K Niazi
Vaccines|September 27, 2025
Engineering Universal Cancer Immunity: Non-Tumor-Specific mRNA Vaccines Trigger Epitope Spreading in Cold TumorsMatthias Magoola, Sarfaraz K Niazi
International Journal of Molecular Sciences|December 17, 2024
Advancing Therapeutic and Vaccine Proteins: Switching from Recombinant to Ribosomal Delivery-A Humanitarian CauseSarfaraz K Niazi, Matthias Magoola
Pharmaceuticals (Basel, Switzerland)|June 27, 2024
Innovative Therapeutic Strategies in Alzheimer's Disease: A Synergistic Approach to Neurodegenerative DisordersSarfaraz K Niazi, Matthias Magoola, Zamara Mariam
International Journal of Molecular Sciences|June 27, 2024
Engineered Antibodies to Improve Efficacy against Neurodegenerative DisordersSarfaraz K Niazi, Zamara Mariam, Matthias Magoola
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biomedicines|April 27, 2024
Transcytosis-Driven Treatment of Neurodegenerative Disorders by mRNA-Expressed Antibody-Transferrin ConjugatesSarfaraz K Niazi, Matthias Magoola
International Journal of Molecular Sciences|December 17, 2024
MicroRNA Nobel Prize: Timely Recognition and High Anticipation of Future Products-A Prospective AnalysisSarfaraz K Niazi, Matthias Magoola
Cancers|June 13, 2025
Current Progress and Future Perspectives of RNA-Based Cancer Vaccines: A 2025 UpdateMatthias Magoola, Sarfaraz K Niazi
Vaccines|September 27, 2025
Engineering Universal Cancer Immunity: Non-Tumor-Specific mRNA Vaccines Trigger Epitope Spreading in Cold TumorsMatthias Magoola, Sarfaraz K Niazi
International Journal of Molecular Sciences|December 17, 2024
Advancing Therapeutic and Vaccine Proteins: Switching from Recombinant to Ribosomal Delivery-A Humanitarian CauseSarfaraz K Niazi, Matthias Magoola
Pharmaceuticals (Basel, Switzerland)|June 27, 2024
Innovative Therapeutic Strategies in Alzheimer's Disease: A Synergistic Approach to Neurodegenerative DisordersSarfaraz K Niazi, Matthias Magoola, Zamara Mariam
International Journal of Molecular Sciences|June 27, 2024
Engineered Antibodies to Improve Efficacy against Neurodegenerative DisordersSarfaraz K Niazi, Zamara Mariam, Matthias Magoola
Pageof 1